# Drugging the 'undruggable' cancer proteins & conserving the Bayeux Tapestry | The chemical breakdown podcast

An episode of [The chemical breakdown & Chemistry in its element](https://invisiblenetwork.ai/podcast/1162733995), 16 Sep 2026, 32 min.

Audio: https://traffic.libsyn.com/secure/chemistryinitselement/18_-_September_9_assembly_mixdown.mp3?dest-id=405840

This week, we explore how molecular glues have revolutionized how we treat previously 'undruggable' cancers and explore how modern scientific techniques are teasing apart the mysteries of one of the most iconic historical artefacts with Phillip Broadwith and Neil Withers. A ground-breaking new drug has become the first of its kind to win FDA approval for metastatic pancreatic cancer. Could it mark the beginning of a new era for cancers that have long been considered impossible to target? We'll also uncover the chemistry behind the investigation and conservation of the Bayeux Tapestry. What secrets have scientists already revealed, and what questions about this iconic artefact remain unanswered? Main stories: https://www.chemistryworld.com/news/us-approves-pancreatic-cancer-treatment-that-targets-undruggable-proteins/4024110.article https://www.chemistryworld.com/features/the-chemistry-helping-to-unravel-the-bayeux-tapestrys-secrets/4024093.article Headlines: https://www.chemistryworld.com/news/does-the-discovery-of-a-new-coronavirus-upend-the-covid-19-lab-leak-hypothesis/4024170.article https://www.chemistryworld.com/news/uk-funding-agency-to-spend-66-million-on-new-methods-for-engineering-the-mitochondrial-genome/4024165.article https://www.chemistryworld.com/news/chinas-scientific-rise-is-being-driven-by-returning-expertise-especially-chemists/4024149.article https://www.chemistryworld.com/news/growing-confidence-of-africas-chemical-societies-brings-chemistrys-benefits-to-continent/4024137.article

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.